private digital health companies obesity management glp-1 Digbi Launches GLP-Fit™ Program: Expands its Precision Biology – Digbi Health GLP-1 Receptor Agonist Market Size

It simultaneously gave brands something in return: the patent term extension mechanism described above and the 30-month litigation stay that gives brands a meaningful chance to litigate patent challenges before generics reach the market

We utilize a specific class of weight loss medication known as GLP-1 and GIP receptor agonists

By law, Medicare cannot cover medications for weight loss, Dr

Phil Murphy (D) in February signed legislation (A5084/S3256) easing penalties for possession of up to an ounce of mushrooms, dropping the punishment to a disorderly persons offense punishable by up to six months in jail and a $1,000 fine instead of up to five years in prison